>
pdufa.bio

APG777

Updated ยทnext FDA decision on the calendar

APG777 is a Apogee Therapeutics, Inc. program. Its next catalyst is a Readout in Nov 2026. Every date links its source.

APGE catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Apogee Therapeutics, Inc. (APGE). We track 3 catalyst events for this program: 1 upcoming and 2 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Aug 2026APGEReadout · Sep 2026APGEReadout · Nov 2026APGE

Questions

When is APG777's next FDA decision or readout?

The next tracked catalyst for APG777 is a Readout in Nov 2026.

What happened at APG777's most recent FDA decision?

No FDA decision for APG777 is in our archive yet.

Who makes APG777?

Apogee Therapeutics, Inc. (APGE).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.